Literature DB >> 19116388

A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.

Paolo Vineis1, Maurizio Manuguerra, Fotini K Kavvoura, Simonetta Guarrera, Alessandra Allione, Fabio Rosa, Alessandra Di Gregorio, Silvia Polidoro, Federica Saletta, John P A Ioannidis, Giuseppe Matullo.   

Abstract

BACKGROUND: Several genes encoding for DNA repair molecules implicated in maintaining genomic integrity have been proposed as cancer-susceptibility genes. Although efforts have been made to create synopses for specific fields that summarize the data from genetic association studies, such an overview is not available for genes involved in DNA repair.
METHODS: We have created a regularly updated database of studies addressing associations between DNA repair gene variants (excluding highly penetrant mutations) and different types of cancer. Using 1087 datasets and publicly available data from genome-wide association platforms, meta-analyses using dominant and recessive models were performed on 241 associations between individual variants and specific cancer types that had been tested in two or more independent studies. The epidemiological strength of each association was graded with Venice criteria that assess amount of evidence, replication, and protection from bias. All statistical tests were two-sided.
RESULTS: Thirty-one nominally statistically significant (ie, P < .05 without adjustment for multiple comparisons) associations were recorded for 16 genes in dominant and/or recessive model analyses (BRCA2, CCND1, ERCC1, ERCC2, ERCC4, ERCC5, MGMT, NBN, PARP1, POLI, TP53, XPA, XRCC1, XRCC2, XRCC3, and XRCC4). XRCC1, XRCC2, TP53, and ERCC2 variants were each nominally associated with several types of cancer. Three associations were graded as having "strong" credibility, another four had modest credibility, and 24 had weak credibility based on Venice criteria. Requiring more stringent P values to account for multiplicity of comparisons, only the associations of ERCC2 codon 751 (recessive model) and of XRCC1 -77 T>C (dominant model) with lung cancer had P <or= .0001 and retained P <or= .001 even when the first published studies on the respective associations were excluded.
CONCLUSIONS: We have conducted meta-analyses of 241 associations between variants in DNA repair genes and cancer and have found sparse association signals with strong epidemiological credibility. This synopsis offers a model to survey the current status and gaps in evidence in the field of DNA repair genes and cancer susceptibility, may indicate potential pleiotropic activity of genes and gene pathways, and may offer mechanistic insights in carcinogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 19116388     DOI: 10.1093/jnci/djn437

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  73 in total

1.  Replication in genome-wide association studies.

Authors:  Peter Kraft; Eleftheria Zeggini; John P A Ioannidis
Journal:  Stat Sci       Date:  2009-11-01       Impact factor: 2.901

2.  Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers.

Authors:  Lori C Sakoda; Melissa M Loomis; Jennifer A Doherty; Liberto Julianto; Matt J Barnett; Marian L Neuhouser; Mark D Thornquist; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-05

3.  Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies.

Authors:  Konstantinos C M Siontis; Nikolaos A Patsopoulos; John P A Ioannidis
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

4.  TP53 codon 72 polymorphism and susceptibility to cervical cancer in the Chinese population: an update meta-analysis.

Authors:  Bing Li; Xin Wang; Hong Chen; Li-Xin Shang; Nan Wu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  The region of XRCC1 which harbours the three most common nonsynonymous polymorphic variants, is essential for the scaffolding function of XRCC1.

Authors:  Audun Hanssen-Bauer; Karin Solvang-Garten; Karin Margaretha Gilljam; Kathrin Torseth; David M Wilson; Mansour Akbari; Marit Otterlei
Journal:  DNA Repair (Amst)       Date:  2012-01-26

6.  Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.

Authors:  Paolo Boffetta; Deborah M Winn; John P Ioannidis; Duncan C Thomas; Julian Little; George Davey Smith; Vincent J Cogliano; Stephen S Hecht; Daniela Seminara; Paolo Vineis; Muin J Khoury
Journal:  Int J Epidemiol       Date:  2012-05-16       Impact factor: 7.196

7.  Polymorphisms in nucleotide excision repair genes and endometrial cancer risk.

Authors:  Jennifer A Doherty; Noel S Weiss; Sherianne Fish; Wenhong Fan; Melissa M Loomis; Lori C Sakoda; Mary Anne Rossing; Lue Ping Zhao; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

8.  Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.

Authors:  Sungshim L Park; Delara Bastani; Binh Y Goldstein; Shen-Chih Chang; Wendy Cozen; Lin Cai; Carlos Cordon-Cardo; Baoguo Ding; Sander Greenland; Na He; Shehnaz K Hussain; Qingwu Jiang; Yuan-Chin A Lee; Simin Liu; Ming-Lan Lu; Thomas M Mack; Jenny T Mao; Hal Morgenstern; Li-Na Mu; Sam S Oh; Allan Pantuck; Jeanette C Papp; Jianyu Rao; Victor E Reuter; Donald P Tashkin; Hua Wang; Nai-Chieh Y You; Shun-Zhang Yu; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Carcinogenesis       Date:  2010-05-17       Impact factor: 4.944

9.  The effect of polymorphism in DNA repair genes RAD51 and XRCC2 in colorectal cancer in Turkish population.

Authors:  Suleyman Cetinkunar; Ilhami Gok; Ruchan Bahadir Celep; Dogan Ilhan; Hasan Erdem; Bulent Caglar Bilgin; Recep Aktimur
Journal:  Int J Clin Exp Med       Date:  2015-02-15

10.  XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.

Authors:  Luis Orlando Pérez; Andrea Crivaro; Gisela Barbisan; Lucia Poleri; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2013-03-29       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.